Fuchs SE (ETR:FPE3 – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as €46.64 ($50.15) and last traded at €45.74 ($49.18), with a volume of 105497 shares. The stock had previously closed at €45.90 ($49.35). Fuchs Stock Down 0.3 % The business […]
Fuchs SE (ETR:FPE3 – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as €46.64 ($50.15) and last traded at €45.74 ($49.18), with a volume of 105497 shares traded. The stock had previously closed at €45.90 ($49.35). Fuchs Price Performance The company has a […]
Fuchs SE (OTCMKTS:FUPBY – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $12.68 and last traded at $12.37, with a volume of 9655 shares trading hands. The stock had previously closed at $12.34. Fuchs Price Performance The firm has a market cap […]
Fuchs SE (FRA:FPE – Get Free Report)’s stock price traded down 1.4% during trading on Tuesday . The company traded as low as €32.60 ($35.43) and last traded at €32.75 ($35.60). 33,761 shares were traded during mid-day trading, The stock had previously closed at €33.20 ($36.09). Fuchs Stock Performance The business has a 50 day […]
Cell therapies show promise for treating eye conditions. One approach injects cultured human corneal endothelial cells with a ROCK inhibitor, yielding positive results in small clinical trials.